Showing results (11-20 of 409) with videos related to

Sort By:
Pageof 41
Drugs of Today (Barcelona, Spain : 1998)|March 7, 2013
The development of regorafenib and its current and potential future role in cancer therapyS L Davis, S G Eckhardt, W A Messersmith, et al.
Oncology (Williston Park, N.Y.)|September 3, 1998
Irinotecan plus cisplatin in patients with advanced non-small-cell lung cancerR Devore, D Johnson, J Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Phase I and pharmacokinetic study of the differentiating agent vesnarinone in combination with gemcitabine in patients with advanced cancerA Patnaik, E K Rowinsky, B K Tammara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignanciesM Hidalgo, L L Siu, J Nemunaitis, et al.
Physical Review. E|August 16, 2020
Hitchhiker model for Laplace diffusion processesM Hidalgo-Soria, E Barkai
British Journal of Cancer|March 5, 2009
Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling studyJ Klawitter, N Anderson, J Klawitter, et al.
Pageof 41